Ventana Invests In Project To Get Companion Diagnostics To Market
This article was originally published in The Pink Sheet Daily
The Critical Path Institute project aims to help the diagnostics industry and FDA coordinate efforts to streamline the regulatory path for tests used to personalize drug treatment.
You may also be interested in...
The high-profile COURAGE trial again raises the question of how soon stents should be placed in patients with coronary disease.
NIH and government agencies plan to submit plans to Congress next month describing ways to encourage the development of medical devices for children.
Do not be cavalier about this venue, drug/device lawyer warns.